J9198 HCPCS code: Injection, gemcitabine hydrochloride, (infugem), 100 mg
J9198 is the HCPCS Level II code for injection, gemcitabine hydrochloride, (infugem), 100 mg. In 2024 Medicare paid an average of $28.97 per service for J9198 across 708 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 38 per day on outpatient hospital claims. Medicare volume fell 86% from 2022 to 2024 (4,899 to 708 services). In 2024, about 12 clinicians billed Medicare for J9198 for 49 beneficiaries.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1D — Chemotherapy |
| Added | 2020-07-01 |
| Last action effective | 2021-01-01 |
Who bills J9198 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 12 |
| Medicare beneficiaries | 49 |
| States with claims | 1 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9198, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,899 | 71 | $24.59 | $19.51 |
| 2023 | 1,147 | 45 | $29.33 | $23.39 |
| 2024 | 708 | 49 | $36.99 | $28.97 |
States with the most J9198 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 260 | $31.58 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 38 | CMS Policy |
| practitioner claims | 38 | CMS Policy |
What changed for J9198
- 2020-07-01: J9198 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9198?
J9198 is the HCPCS Level II code for injection, gemcitabine hydrochloride, (infugem), 100 mg. Short descriptor: "Inj. infugem, 100 mg".
How much does Medicare pay for J9198?
In 2024, the average Medicare payment was $28.97 per service (average allowed $36.99).
Does Medicare cover J9198?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9198 can be billed per day?
38 on outpatient hospital claims; 38 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9198
- Watch J9198 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9198
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.